Proteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%

MT Newswires Live

2025/03/28

Proteomics International Laboratories' (ASX:PIQ) OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.

OxiDx was designed to detect oxidative stress through a finger-prick blood sample.

The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.

The second-generation patent is pending in the US, Singapore, India, and China, the filing added.

The diagnostics company's shares were up 4% in recent Friday trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2522598046"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522598046\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2522598046?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-28 11:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522598046","market":"hk","top_or_hot":-1,"title":"Proteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%","media":"MT Newswires Live","content":"<html><body><p> Proteomics International Laboratories' (ASX:PIQ) OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.</p><p>OxiDx was designed to detect oxidative stress through a finger-prick blood sample.</p><p>The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.</p><p>The second-generation patent is pending in the US, Singapore, India, and China, the filing added.</p><p>The diagnostics company's shares were up 4% in recent Friday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Proteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-28 11:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Proteomics International Laboratories' (ASX:PIQ) OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.</p><p>OxiDx was designed to detect oxidative stress through a finger-prick blood sample.</p><p>The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.</p><p>The second-generation patent is pending in the US, Singapore, India, and China, the filing added.</p><p>The diagnostics company's shares were up 4% in recent Friday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522598046","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522598046","pubTimestamp":1743133202,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Proteomics International Laboratories'  OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.OxiDx was designed to detect oxidative stress through a finger-prick blood sample.The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.The second-generation patent is pending in the US, Singapore, India, and China, the filing added.The diagnostics company's shares were up 4% in recent Friday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7048":"生命科学工具和服务","XKO.AU":"标普/澳交所 300指数","XAO.AU":"标普/澳交所 普通股指数","PIQ.AU":"PROTEOMICS INTERNATIONAL LAB","XJO.AU":"标普/澳交所 200指数"},"translate_title":"蛋白质组学表示，该部门获得了氧化应激诊断测试的新澳大利亚专利；股价上涨4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XJO.AU":1,"XAO.AU":1,"PIQ.AU":0.9,"XKO.AU":1},"content_text":"Proteomics International Laboratories' (ASX:PIQ) OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.OxiDx was designed to detect oxidative stress through a finger-prick blood sample.The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.The second-generation patent is pending in the US, Singapore, India, and China, the filing added.The diagnostics company's shares were up 4% in recent Friday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}